Kymera Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 30, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Founders
- Laurent Audoly
- Company Description
- Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
- Market
- Targeted protein degradation
- Location
- Cambridge, MA, USA
- Coinvestors
- Amgen Business Development, Atlas Venture